Healsun Biopharm
PrivateLast Round
Series C
Nov 19, 2023
Total Funding Raised
$83.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Healsun Biopharm operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series C round in November 2023.
Healsun Biopharm is a biotechnology company that provides one-stop CDMO services for antibody, fusion protein, and antibody-drug conjugate (ADC) development, ranging from protein engineering and CMC process development to commercial production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Drug Discovery, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healsun Biopharm Comparables
Compare Healsun Biopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asymchem | 74% | |
| Intellective Biologics (Suzhou) Co., Ltd. | 74% | |
| WuXi AppTec | 73% |
For institutional investors. Book with your work email.
Healsun Biopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 19, 2023 | ||||
| Series B | Oct 7, 2023 | ||||
| Series B | Aug 18, 2022 | ||||
| Series A | Apr 12, 2021 | ||||
| Series A | Aug 9, 2018 |
For institutional investors. Book with your work email.
Healsun Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hangzhou Oriental Jiafu Asset Management Co., Ltd. | Series B |
| Zhejiang Sino Wisdom Investment Management | Series A |
| Haitong Capital | Series B |
| Zhejiang Haibang Private Equity Fund Management Co., Ltd. | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 378% MoM, reaching 1K.
- Aug 18, 2022
$37M round with participation from Haitong Capital.
For institutional investors. Book with your work email.
Healsun Biopharm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Healsun Biopharm's valuation, stock price, and market status.
Is Healsun Biopharm a public or private company?
Healsun Biopharm is a private company.
What is the current stock price of Healsun Biopharm?
Healsun Biopharm is a private company, so its shares have no public market price. Caplight tracks Healsun Biopharm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Healsun Biopharm worth (valuation)?
Valuation information for Healsun Biopharm is not publicly available.
Can I buy Healsun Biopharm stock?
Healsun Biopharm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Healsun Biopharm's last funding round?
Healsun Biopharm's most recent funding round was Series C on November 19, 2023.
Who are the main investors in Healsun Biopharm?
Key investors in Healsun Biopharm include Zhejiang Haibang Private Equity Fund Management Co., Ltd..
Will Healsun Biopharm IPO soon?
No public IPO plans have been announced for Healsun Biopharm.
How can I track Healsun Biopharm secondary market activity?
Caplight tracks bids, offers, and trades in Healsun Biopharm's shares on secondary markets.